ctrl K

Watchlist Price Alert

Athira Pharma Inc. (ATHA)

NASDAQ: ATHA · Real-Time Price · USD

0.26

-0.02 (-7.14%)

At close: May 14, 2025, 3:59 PM

0.26

1.73%

After-hours: May 14, 2025, 06:15 PM EDT

Athira Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	969K	1.05M	479K	2M	n/a	n/a
Gross Profit	n/a	-969K	-1.05M	-479K	-2M	n/a	n/a
Operating Income	-96.78M	-125.47M	-104.02M	-64.02M	-20M	-5.45M	-5.01M
Interest Income	n/a	7.64M	3.22M	337K	124K	51K	85K
Pretax Income	-96.94M	-117.67M	-95.64M	-54.85M	-19.95M	-5.16M	-5.1M
Net Income	-96.94M	-117.67M	-87.26M	-54.37M	-18.63M	-4.7M	-5.1M
Selling & General & Admin	26.09M	33.3M	32.55M	21.23M	6.71M	1.66M	1.42M
Research & Development	70.68M	92.82M	61.46M	42.79M	13.29M	3.79M	3.59M
Other Expenses	n/a	-1.63M	-5.16M	-8.84M	-1.32M	-754K	-164K
Operating Expenses	100.9M	125.47M	88.86M	55.19M	18.67M	4.7M	5.01M
Interest Expense	n/a	n/a	24.32M	3K	367K	346K	9K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	125.47M	88.86M	55.19M	18.67M	4.7M	5.01M
Income Tax Expense	n/a	n/a	-8.38M	-479K	-1.32M	-459K	-76K
Shares Outstanding (Basic)	38.48M	38.02M	37.73M	36.92M	32.49M	32.62M	3.26
Shares Outstanding (Diluted)	38.48M	38.02M	37.73M	36.92M	32.49M	32.62M	3.26
EPS (Basic)	-2.52	-3.09	-2.31	-1.47	-0.57	-0.14	-1.56M
EPS (Diluted)	-2.52	-3.09	-2.31	-1.47	-0.57	-0.14	-1.56M
EBITDA	-95.97M	-116.7M	-94.59M	-54.37M	-19.01M	-4.82M	-79K
EBIT	-96.94M	-117.67M	-95.64M	-54.85M	-19.59M	-4.82M	-5.09M
Depreciation & Amortization	970K	969K	1.05M	479K	2M	2K	5.01M